Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2019/0062328 BRUTON'S TYROSINE KINASE INHIBITORS
Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I): ##STR00001##
2019/0062327 BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are...
2019/0062326 2-PHENYL-3-(PIPERAZINOMETHYL)IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS BLOCKERS OF TASK-1 AND TASK-2 CHANNELS, FOR...
The present application relates to novel 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives, to processes for their preparation, to their use...
2019/0062325 NOVEL DIHYDROPYRIDOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY...
A compound according to Formula I: ##STR00001## wherein R.sup.1, L.sub.A, Cy.sub.A, R.sup.A, R.sup.2, R.sup.3, and R.sup.4 are as described herein. The present...
2019/0062324 AUTOTAXIN INHIBITORS
The present invention relates to compounds of formula I ##STR00001## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4a, R.sub.4b, R.sub.4c, R.sub.4d, L, A, Q, W and...
2019/0062323 PI-Kinase Inhibitors with Anti-Infective Activity
Compounds and methods are provided for the treatment of pathogen infections. In some embodiments, the anti-infective compounds have broad spectrum activity...
2019/0062322 PUMA INHIBITOR, METHOD FOR PREPARATION THEREOF, AND USE THEREOF
The present invention relates to the technical field of medicine, and specifically relates to a PUMA inhibitor, a method for preparation thereof, and a use...
2019/0062321 HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF
Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, or pharmaceutically acceptable salts thereof, compositions thereof, and methods of...
2019/0062320 ETHER COMPOUNDS AND USES THEREOF
The present invention provides compounds that modulate protein function, to restore protein homeostasis and/or cell-cell adhesion. The invention provides...
2019/0062319 Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders
The invention relates to novel heterocyclic compounds of the formula ##STR00001## in which all of the variables are as defined in the specification, ...
2019/0062318 COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS
Disclosed is a compound of formula (I). or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions including the compound of...
2019/0062317 COMPOUNDS
Anti-angiogenic treatments, for example treatment of ocular neovascularization or cancer, treatments of hyperpermeability disorders, treatments of neuropathic...
2019/0062316 PROCESS FOR THE SEPARATION OF ENANTIOMERS OF PIPERAZINE DERIVATIVES
##STR00001## The invention relates to a process for preparing either enantiomer of a compound of formula (I), wherein X, Y and n have the meaning given in ...
2019/0062315 PYRIDONE DERIVATIVE COMPRISING HETEROATOMIC RING BUTANE SUBSTITUENT, FOR TREATING FIBROSIS AND INFLAMMATORY...
Disclosed is a compound for treating fibrosis-related diseases, and specifically disclosed are the compound represented by formula (I) and a pharmaceutically...
2019/0062314 COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): ##STR00001## or a...
2019/0062313 COVALENT INHIBITORS OF KRAS
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): ##STR00001## or a...
2019/0062312 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES
Organic molecules are provided that exhibit emission maxima in the blue, sky-blue or green spectral range. The organic molecules exhibit emission maxima...
2019/0062311 QUINOXALINE AND PYRIDOPYRAZINE DERIVATIVES AS PI3KB INHIBITORS
The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula (I) ##STR00001## wherein the variables have the meaning...
2019/0062310 TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, ester, stereoisomer, tautomer, solvate, hydrate, or combination...
2019/0062309 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
The present disclosure provides a compound of Formula (I'): ##STR00001## or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or...
2019/0062308 1,3,5-TRIAZINE DERIVATIVE AND METHOD OF USING SAME
Disclosed are compounds having formulae I and II or pharmaceutically acceptable salts or hydrates thereof, a preparation method thereof and pharmaceutical...
2019/0062307 DEUTERIUM-SUBSTITUTED QUINOLINE DERIVATIVES
The present application provides deuterium-substituted quinoline derivatives, preparation methods thereof and uses thereof. In particular, the present...
2019/0062306 BENZAZEPINE COMPOUNDS, CONJUGATES, AND USES THEREOF
Benzazepine compounds, conjugates, and pharmaceutical compositions for use in the treatment of disease, such as cancer, are disclosed herein. The disclosed...
2019/0062305 PYRIDYL OR PYRAZINYL COMPOUNDS CARRYING A METHYL-BOUND ALPHA-AMINO ACID AMIDE GROUP
The present invention relates to pyridyl or pyrazinyl compounds carrying a methyl-bound N-amide moiety derived from an .alpha.-amino acid of formula I where...
2019/0062304 TETRAHYDROISOQUINOLINES AS PRMT5 INHIBITORS
A compound of formula (I) wherein: n is 1 or 2; p is 0 or 1; R.sup.1a, R.sup.1b, R.sup.1c and R.sup.1d are independently selected from H, M halo, methyl and...
2019/0062303 SUBSTITUTED QUINAZOLINE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY
Disclosed are new small molecules having a substituted quinazoline core structure and the uses thereof for modulating glucocerebrosidase activity. Also...
2019/0062302 Inhibitors of PARPs that catalyze mono-ADP-ribosylation
Provided herein are compounds of Formula I, or a pharmaceutically acceptable salt thereof: ##STR00001## which are useful as PARP inhibitors, as well as...
2019/0062301 CYCLOPROPYLAMINES AS LSD1 INHIBITORS
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
2019/0062300 SUBSTITUTED BENZOTHIOPHENYL DERIVATIVES AS GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are...
2019/0062299 PROCESSES FOR THE PREPARATION OF HETEROARYL CARBOXYLIC ACIDS
Provided herein are processes for the preparation of heteroaryl carboxylic acids.
2019/0062298 INDENE DERIVATIVES AND USES THEREOF
The present invention relates to compounds of formula (I): ##STR00001## including any stereochemically isomeric form thereof, or pharmaceutically acceptable...
2019/0062297 Compositions Comprising an Urolithin Compound
The invention provides compositions comprising a source of protein and a urolithin. The invention also provides uses and methods associated with, or making use...
2019/0062296 Process for Preparing Oroxylin A
A process for preparing oroxylin A includes: subjecting baicalin to a methylation reaction using a methylating reagent in the presence of a base to methylate...
2019/0062295 PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE BERAPROST
The invention provides a new process for the preparation of optically active Beraprost of formula (I) starting from racemic Beraprost alkyl ester through...
2019/0062294 METHOD FOR PRODUCING 2-ALKYLCARBONYLNAPHTHO[2,3-b]FURAN-4,9-DIONE-RELATED SUBSTANCE, AND SAID RELATED SUBSTANCE
Provided is a method for producing a 2-alkylcarbonylnaphtho[2,3-b]furan-4,9-dione-related substance, which is suitable for the production on an industrial...
2019/0062293 METAL-ORGANIC FRAMEWORKS FOR THE CONVERSION OF LIGNOCELLULOSIC DERIVATIVES TO RENEWABLE PLATFORM CHEMICALS
Methods of processing lignocellulose using metal-organic frameworks (MOFs) to form renewable platform chemicals that may be used as initial feedstock are...
2019/0062292 METHODS FOR PURIFYING 5-(HALOMETHYL)FURFURAL
The present disclosure provides methods for purifying a 5-(halomethyl)furfural composition, including 5-(chloromethyl)furfural, at operating conditions that...
2019/0062291 Oligomeric (TH)FP, production and uses therefor
A method for the isolation of oligomeric 2, 2-difurylpropane (DTHFP) suitable for use on an industrial scale. A method can include using oligomeric 2,...
2019/0062290 2,3-Epoxy Succinyl Derivative, Preparation Method and Use Thereof
The present invention relates to a 2,3-epoxy succinyl derivative, a preparation method and a use thereof, in particular, the present invention relates to a...
2019/0062289 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR...
A polymerizable compound has a practical low melting point, excellent solubility in a general-purpose solvent, and can produce an optical film at low cost,...
2019/0062288 3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
The present disclosure relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with an...
2019/0062287 INSENSITIVE PLASTICIZER AND MELT-CASTABLE ENERGETIC MATERIAL
A method and compound includes mixing dichloroglyoxime with an alcohol containing an alkyne functional group in methanol to create a mixture; adding a salt...
2019/0062286 NOVEL ALKYLATED DIPHENYLAMINE DERIVATIVES OF TRIAZOLE AND LUBRICATING COMPOSITIONS CONTAINING THE SAME
Novel compounds are described, being alkylated diphenylamine derivatives of triazole, wherein the alkyl group on at least one of the phenyl groups is C8 or...
2019/0062285 BENZIMIDAZOL-2-AMINES AS MIDH1 INHIBITORS
The present invention relates to benzimidazol-2-amines of general formula (I), in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8,...
2019/0062284 SMALL MOLECULE INHIBITORS OF DYRK1A AND USES THEREOF
This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a benzimidazole or...
2019/0062283 COMPOSITIONS AND METHODS FOR MODULATING FARNESOID X RECEPTORS
The present invention relates to compounds of Formula I, ##STR00001## a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate...
2019/0062282 HETEROCYCLE AND CARBOCYCLE DERIVATIVES HAVING TRKA INHIBITORY ACTIVITY
The present invention relates to a compound represented by Formula (I): ##STR00001## wherein -L- is --C(.dbd.X)--, or the like, --Z-- is --NR.sup.5--, or the ...
2019/0062281 Substituted Heterocycles as c-MYC Targeting Agents
Disclosed are substituted heterocycle compounds including substituted pyrazoles, substituted pyrimidines, and substitute triazoles. The substituted...
2019/0062280 METHOD FOR PRODUCING 4,4,7-TRIFLUORO-1,2,3,4-TETRAHYDRO-5H-1-BENZAZEPINE COMPOUND AND INTERMEDIATE USED IN THE...
The present invention provides a method for producing a 4,4,7-trifluoro-1,2,3,4-tetrahydro-5H-1-benzazepine compound which has an superior agonistic activity...
2019/0062279 COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID...
The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.